Regen BioPharma Inc (RGBP)

[Carter]

Keep in mind the valuation of Translate Bio... their lead candidate treats CF (cystic fibrosis).

[Edit] Compare the global market size of CF to cancer...

---> The global cystic fibrosis therapeutics market size was valued at $5.1B in 2018 and is expected to reach $31.9B by 2027

---> The global oncology drugs market size was valued at $141B in 2019 & is projected to reach $394B by 2027

--------------------------------------------------------

Therefore it stands to reason the pipeline of pre-clinical candidates that treat cancer would be valued at an exponential to candidates that treat CF. (see Kite Pharma's ~$12B acquisition.)

---------------------------------------------------------

The key here is big pharma is in a race to build out their clinical pipelines with next-class mRNA treatments.